Clinical Trial Update: Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator

View source ↗

Summary

A completed clinical trial comparing rituximab biosimilars to the originator in ANCA-associated vasculitis, including granulomatosis with polyangiitis and micro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: ANCA-associated Vasculitis, Granulomatosis With Polyangiitis | Status: COMPLETED